BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28609115)

  • 1. Molecular targets of dietary phytochemicals for possible prevention and therapy of uterine fibroids: Focus on fibrosis.
    Islam MS; Akhtar MM; Segars JH; Castellucci M; Ciarmela P
    Crit Rev Food Sci Nutr; 2017 Nov; 57(17):3583-3600. PubMed ID: 28609115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?
    Islam MS; Akhtar MM; Ciavattini A; Giannubilo SR; Protic O; Janjusevic M; Procopio AD; Segars JH; Castellucci M; Ciarmela P
    Mol Nutr Food Res; 2014 Aug; 58(8):1667-84. PubMed ID: 24976593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix in uterine leiomyoma pathogenesis: a potential target for future therapeutics.
    Islam MS; Ciavattini A; Petraglia F; Castellucci M; Ciarmela P
    Hum Reprod Update; 2018 Jan; 24(1):59-85. PubMed ID: 29186429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary phytochemicals for possible preventive and therapeutic option of uterine fibroids: Signaling pathways as target.
    Islam MS; Segars JH; Castellucci M; Ciarmela P
    Pharmacol Rep; 2017 Feb; 69(1):57-70. PubMed ID: 27898339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of uterine leiomyomas.
    Vilos GA; Allaire C; Laberge PY; Leyland N;
    J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine leiomyoma: available medical treatments and new possible therapeutic options.
    Islam MS; Protic O; Giannubilo SR; Toti P; Tranquilli AL; Petraglia F; Castellucci M; Ciarmela P
    J Clin Endocrinol Metab; 2013 Mar; 98(3):921-34. PubMed ID: 23393173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.
    Segars JH; Parrott EC; Nagel JD; Guo XC; Gao X; Birnbaum LS; Pinn VW; Dixon D
    Hum Reprod Update; 2014; 20(3):309-33. PubMed ID: 24401287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EMAS position statement: management of uterine fibroids.
    Pérez-López FR; Ornat L; Ceausu I; Depypere H; Erel CT; Lambrinoudaki I; Schenck-Gustafsson K; Simoncini T; Tremollieres F; Rees M;
    Maturitas; 2014 Sep; 79(1):106-16. PubMed ID: 24975954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase inhibitors for uterine fibroids.
    Song H; Lu D; Navaratnam K; Shi G
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009505. PubMed ID: 24151065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenomic and enhancer dysregulation in uterine leiomyomas.
    Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
    Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic management of uterine fibroid tumors: updated French guidelines.
    Marret H; Fritel X; Ouldamer L; Bendifallah S; Brun JL; De Jesus I; Derrien J; Giraudet G; Kahn V; Koskas M; Legendre G; Lucot JP; Niro J; Panel P; Pelage JP; Fernandez H;
    Eur J Obstet Gynecol Reprod Biol; 2012 Dec; 165(2):156-64. PubMed ID: 22939241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging treatment options for uterine fibroids.
    Donnez J; Arriagada P; Donnez O; Dolmans MM
    Expert Opin Emerg Drugs; 2018 Mar; 23(1):17-23. PubMed ID: 29486606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids.
    Islam MS; Afrin S; Singh B; Jayes FL; Brennan JT; Borahay MA; Leppert PC; Segars JH
    Clin Transl Med; 2021 Jul; 11(7):e475. PubMed ID: 34323413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adlay (
    Lin PH; Shih CK; Yen YT; Chiang W; Hsia SM
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31010220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.
    Ahmed RS; Liu G; Renzetti A; Farshi P; Yang H; Soave C; Saed G; El-Ghoneimy AA; El-Banna HA; Foldes R; Chan TH; Dou QP
    J Cell Biochem; 2016 Oct; 117(10):2357-69. PubMed ID: 26950525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine fibroids associated with infertility.
    Van Heertum K; Barmat L
    Womens Health (Lond); 2014 Nov; 10(6):645-53. PubMed ID: 25482490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highlights on Medical Treatment of Uterine Fibroids.
    Angioni S; D'Alterio MN; Daniilidis A
    Curr Pharm Des; 2021; 27(36):3821-3832. PubMed ID: 33388011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B; Havelock J; Hemmings R; ;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Medical Management for Uterine Leiomyomas.
    Kashani BN; Centini G; Morelli SS; Weiss G; Petraglia F
    Best Pract Res Clin Obstet Gynaecol; 2016 Jul; 34():85-103. PubMed ID: 26796059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.